Literature DB >> 20142256

Colorectal cancer susceptibility quantitative trait loci in mice as a novel approach to detect low-penetrance variants in humans: a two-stage case-control study.

Ceres Fernández-Rozadilla1, Rosa Tarrío, Juan Clofent, Luisa de Castro, Alejandro Brea-Fernández, Xavier Bessa, Anna Abulí, Montserrat Andreu, Rodrigo Jover, Rosa Xicola, Xavier Llor, Antoni Castells, Sergi Castellví-Bel, Angel Carracedo, Clara Ruiz-Ponte.   

Abstract

Thirty-five percent of colorectal cancer (CRC) susceptibility is thought to be attributable to genetics, but only a small proportion of the cases (<6%) can be explained by highly penetrant mutations. The rest of the susceptibility could be explained by a number of low-penetrance variants following a polygenic model of inheritance. Genetic modeling in rodents has been a successful tool for the unraveling of the genetic basis of diseases. The investigation of mouse quantitative trait loci led to the discovery of 15 "susceptibility to colorectal cancer" (Scc) loci. Thus, we aimed to analyze the human-mouse syntenic regions defined by these Scc loci and select human candidate genes within. Twenty-one genes were chosen and their single-nucleotide polymorphisms were tested as possible low-penetrance variants predisposing to CRC risk. Our most strongly associated single-nucleotide polymorphism, rs954353, seems to be in the 5' region of the CYR61 gene, which could implicate it in terms of the cis-regulation of the gene. CYR61 has been proposed as a connection point among signaling pathways and a probable marker for early CRC detection. However, we could not replicate the association. Despite our negative results, we believe that our candidate gene selection strategy could be quite useful in the future determination of variants predisposing to disease.

Entities:  

Mesh:

Year:  2010        PMID: 20142256     DOI: 10.1158/1055-9965.EPI-09-1175

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  4 in total

Review 1.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets.

Authors:  Joon-Il Jun; Lester F Lau
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

2.  Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins.

Authors:  Anna Abulí; Ceres Fernández-Rozadilla; Virginia Alonso-Espinaco; Jenifer Muñoz; Victoria Gonzalo; Xavier Bessa; Dolors González; Joan Clofent; Joaquin Cubiella; Juan D Morillas; Joaquim Rigau; Mercedes Latorre; Fernando Fernández-Bañares; Elena Peña; Sabino Riestra; Artemio Payá; Rodrigo Jover; Rosa M Xicola; Xavier Llor; Luis Carvajal-Carmona; Cristina M Villanueva; Victor Moreno; Josep M Piqué; Angel Carracedo; Antoni Castells; Montserrat Andreu; Clara Ruiz-Ponte; Sergi Castellví-Bel
Journal:  BMC Cancer       Date:  2011-08-05       Impact factor: 4.430

3.  A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22.

Authors:  A Abulí; C Fernández-Rozadilla; M D Giráldez; J Muñoz; V Gonzalo; X Bessa; L Bujanda; J M Reñé; A Lanas; A M García; J Saló; L Argüello; A Vilella; R Carreño; R Jover; R M Xicola; X Llor; L Carvajal-Carmona; I P M Tomlinson; D J Kerr; R S Houlston; J M Piqué; A Carracedo; A Castells; M Andreu; C Ruiz-Ponte; S Castellví-Bel
Journal:  Br J Cancer       Date:  2011-08-02       Impact factor: 7.640

4.  Genetic associations in the vitamin D receptor and colorectal cancer in African Americans and Caucasians.

Authors:  Sonia S Kupfer; Jeffrey R Anderson; Anton E Ludvik; Stanley Hooker; Andrew Skol; Rick A Kittles; Temitope O Keku; Robert S Sandler; Clara Ruiz-Ponte; Sergi Castellvi-Bel; Antoni Castells; Angel Carracedo; Nathan A Ellis
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.